RVNC
Revance Therapeutics, Inc.
CFO, CBO, Secretary Lauren P Silvernail sold $268K of Revance Therapeutics, Inc.
Sold$268,267
$26.83Price
10,000Shares
−17%Stake
What RVNC did after the filing
Prices for RVNC after this filing aren't in yet.
Traded Tue, Nov 7. Filed Thu, Nov 9, 2:46 PM ET, during the session. Not investment advice.